AnX Robotica Corp

In 2020, AnX Robotica attained FDA De Novo clearance for the NaviCam™ Stomach System, the world’s first commercialized robotic control platform for gastrointestinal visualization and is working to expand the platform for various additional diagnostic aids and therapeutic applications.

The NaviCam™ Stomach System has achieved a medical milestone by enabling a physician to have complete control while conducting a stomach examination with a minimally invasive, patient-friendly procedure. By simply swallowing a pill-sized capsule, patients can undergo a thorough stomach examination with no sedation.

Our NaviCam ™ SB* System with ProScan™* Reading Support, utilizes our innovative intelligent software to dramatically reduce reading time with unmatched sensitivity. The addition of novel aspherical lens technology provides superior optics, reducing distortion. (*NaviCam SB and ProScan are not available for sale in the US).

Headquartered in Plano, Texas, AnX Robotica brings versatility in development and integration of multi-discipline technologies such as precise magnetic, robotic control, in house ASIC design, artificial intelligence, micro-optical imaging, image processing, and wireless transmission. With more than 200 patents granted or applications pending, and dozens of clinical papers published in major international journals, AnX Robotica, together with its sister companies, have become the leading companies in robotic capsule technology.

Company’s Keywords:

capsule endoscopy, gastroenterology, endoscopy, robotics, diagnostic medical equipment, gastrointestinal, vibrating capsule, radiopaque markers, artificial intelligence, small bowel, stomach, esophagus, colon, imaging, magnetic control, motility, constipation, gi bleeding